
The November Issue of Pharmafocus is now live!
pharmafile | October 26, 2016 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â Pharmafocus, features, latest news, newsÂ
The latest issue of Pharmafocus is now live and ready to be read! We’ve taken the opportunity to cover some of the biggest recent news stories, particularly focusing on Roche’s latest data on Tecentriq and how that’s going to impact on the highly competitive immunotherapy field.
We take a closer look at Real World Evidence to examine how this promising research practicee could address the increasing problems of clinical trial-based data collection. Following on from this, we take a look at the issues facing clinical trials in a double feature, focusing on recruitment and retention and how social media and apps may offer a solution.
Branching out from clinical trials, we return to the issue of price hiking as the permutations from the Mylan EpiPen scandal continue to cause reverberations throughout the pharmaceutical industry; we delve into one of the US’ biggest pharma problems.
Related Content

Rare disease clinical trials: the urgent need for patients to be heard
Ahead of Clinical Trials Day, Soraya Bekkali, from Alexion, AstraZeneca Rare Disease, highlights the urgent …

Sustainability in pharma
Betsy Goodfellow from Pharmafocus considers the need for sustainable practices in the pharma industry and assesses various …

Phamafile.com’s top 10 news stories of the week
Among our top 10 stories this week: A study has found the Pfizer COVID-19 vaccine …






